Social circumstances of initiation of injection drug use and early shooting gallery attendance: Implications for HIV intervention among adolescent and young adult injection drug users

Journal of Acquired Immune Deficiency Syndromes

Volumn 32, Issue 1, 2003, Pages 86-93

  Fuller, Crystal M ^a   Vlahov, David ^a,b   Latkin, Carl A ^d   Ompad, Danielle C ^c   Celentano, David D ^c   Strathdee, Steffanie A ^c  

^a Columbia University ^*  (United States)

^b NEW YORK ACADEMY OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d Department of Epidemiology ^*

Author keywords

HIV; Injection drug users; Shooting gallery; Social networks; Young

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INJECTION; INTRAVENOUS DRUG ABUSE; JUVENILE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE; SEX RATIO; SOCIAL BEHAVIOR; SPORT;

EID: 0037235975     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200301010-00013     Document Type: Article

References (47)

1. Nelson KE, Vlahov D, Solomon L, et al. Temporal trends of incident human immunodeficiency virus infection in a cohort of injection drug users in Baltimore, Maryland. Arch Intern Med 1995;155:1305-11.
2. Nicolosi A, Leite MLC, Molinari S, et al. Incidence and prevalence trends of HIV infection in intravenous drug users attending treatment centers in Milan and Northern Italy, 1986-1990. J Acquir Immune Defic Syndr Hum Retrovirol 1992;5:365-73.
3. Vlahov D, Anthony JC, Celentano DD, et al. Trend of HIV-1 risk reduction among initiates into intravenous drug use 1982-1987. Am J Drug Alcohol Abuse 1991;17:39-48.
4. van Ameijden EJC, van den Hoek JAR, Mientjes GHC, et al. A longitudinal study on the incidence and patterns of HIV, HBV, and HCV infection among drug users in Amsterdam. Eur J Epidemiol 1993;9:255-62.
5. Garfein RS, Vlahov D, Galai N, et al. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency virus, and human T-lymphotropic viruses. Am J Public Health 1996;86:655-61.
6. Garfein RS, Doherty MC, Monterroso ER. et al. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18(Suppl):S 11-9.
7. Thomas DL, Vlahov D, Solomon L, et al. Correlates of hepatitis C virus infection among injection drug users. Medicine 1995;74:212-20.
8. Villano SA, Vlahov D, Nelson KE. et al. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J Clin Microbiol 1997;35:3274-7.
9. van Ameijden EJC, van den Hoek JAR, van Haastrecht HJA, et al. The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam. Am J Epidemiol 1992;136:236-43.
10. Fennema JSA, van Ameijden EJC, van den Hoek A, et al. Young and recent-onset injecting drug users are at higher risk for HIV. Addiction 1997;92:1457-65.
11. Booth R, Koester S, Brewster JT, et al. Intravenous drug users and AIDS: risk behaviors. Am J Drug Alcohol Abuse 1991;17:337-53.
12. Marrero Rodriguez CA, Robles RR, Colon HM, et al. HIV risk behaviors and HIV seropositivity among young injection drug users. PR Health Sci J 1993;12:7-12.
13. Telles PR, Bastos FI, Guydish J, et al. Risk behavior and HIV seroprevalence among injecting drug users in Rio de Janeiro, Brazil. AIDS 1997;(Suppl 1):S35-42.
14. Carneiro M, Fuller C, Doherty MC, et al. HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old. Drug Alcohol Depend 1999;54:83-6.
15. Des Jarlais DC, Friedman SR, Perlis T, et al. Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. J Acquir Immune Defic Syndr 1999;20:67-72.
16. Doherty MC, Garfein RS, Monterroso EM, et al. Correlates of HIV infection among young adult short-term injection drug users. AIDS 2000;14:717-26.
17. Battjes RJ, Leukefeld CG, Pickens RW. Age at first injection and HIV risk among intravenous drug users. Am J Drug Abuse 1992;18:263-73.
18. Roy E, Haley N, Boivin JY, et al. Predictors of drug injection initiation in a street youth cohort [abstract 33389]. Presented at the 12th World AIDS Conference, Geneva, June 1998.
19. Diaz T, Conover S, Edwards V, et al. Drug using behaviors of young and recent initiate injection drug users in New York City: a unique opportunity for prevention of HIV [abstract 23228]. Presented at the 12th World AIDS Conference, Geneva, June 1998.
20. Valente TW, Foreman RK, Junge B, et al. Needle-exchange participation, effectiveness, and policy: syringe relay, gender, and the paradox of public health. J Urban Health 2001;78:340-9.
21. Marmor M, Des Jarlais DC, Cohen H, et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS 1987;1:39-44.
22. Schoenbaum EE, Hartel D, Selwyn PA. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med 1989;321:874-9.
23. Chaisson RE, Bacchetti P, Osmond D, et al. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 1989;26:561-5.
24. Vlahov D, Munoz A, Anthony JC. et al. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am J Epidemiol 1990;132:847-56.
25. Koblin BA, McCusker J, Lewis BJ, et al. Racial/ethnic differences in HIV-I seroprevalence and risky behaviors among intravenous drug users in a multisite study. Am J Epidemiol 1990;132:837-46.
26. Nelson KE, Vlahov D, Cohn S, et al. Sexually transmitted diseases in a population of intravenous drug users: association with seropositivity to the human immunodeficiency virus (HIV). J Infect Dis 1991;164:457-63.
27. Moss AR, Vranizan K, Gorter R, et al. HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. AIDS 1994;8:223-31.
28. Battjes RJ, Pickens RW, Haverkos HW, et al. HIV risk factors among injecting drug users in five US cities. AIDS 1994;8:681-7.
29. Strathdee SA, Galai N, Safaiean M, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a ten year perspective. Arch Int Med 2001;161:1281-8.
30. Neaigus A, Friedman SR, Jose B, et al. High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:499-509.
31. Page BJ. Shooting scenarios and risk of HIV-1 infection. Am Behav Sci 1990;33:478-90.
32. Fuller C, Vlahov D, Ompad DC, et al. Correlates of HIV infection among newly initiated adolescent and young adult injection drug users (REACH II) [abstract]. Presented at the 32nd Annual Meeting Society for Epidemiologic Research, Baltimore, 1999.
33. Anthony JC, Vlahov D, Celentano DD, et al. Self-report interview data for study of HIV-1 infection among intravenous drug users: description of methods and preliminary evidence on validity. J Drug Issues 1991;21:739-57.
34. Samuels JF, Vlahov D, Anthony JC, et al. Measurement of HIV risk behaviors among intravenous drug users. Br J Addict 1992;87:417-28.
35. Monterroso ER, Hamburger ME, Vlahov D, et al. Prevention of HIV infection in street-recruited injection drug users. J Acquir Immune Defic Syndr 2000;25:63-70.
36. Celentano D, Vlahov D, Cohn S, et al. Risk factors for shooting gallery use and cessation among intravenous drug users. Am J Public Health 1991;81:1291-5.
37. Robles RR, Marrero CA, Reyes JC, et al. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:477-83.
38. Latkin CA, Forman Valerie L. Patterns of needle acquisition and sociobehavioral correlates of needle exchange program attendance in Baltimore, Maryland, U.S.A. J Acquir Immune Defic Syndr 2001;27:398-404.
39. Archibald CP, Ofner M, Strathdee SA, et al. Factors associated with frequent needle exchange program attendance in injection drug users in Vancouver, Canada. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:160-6.
40. Reardon J, Wilson MJ, Lemp GF. et al. HIV-1 infection among female injection drug users (IDU) in the San Francisco Bay Area, California, 1989-1991 [abstract Th.C.1553]. Presented at the VIII International Conference on AIDS, Amsterdam, July 1992.
41. Friedman SR, Des Jarlais DC, Deren S, et al. HIV seroconversion among female drug injectors who have sex with women [abstract]. Presented at the 120th Annual Meeting of the American Public Health Association, New York, 1992.
42. Magura S, Kang S, Shapiro J, et al. HIV risk among women injecting drug users who are in jail. Addiction 1993;88:1351-60.
43. Latkin C. Outreach in natural settings: The use of peer leaders for HIV prevention among injection drug users' networks. Public Health Rep 1998;113(Suppl):151-9.
44. Chitwood DD, McCoy CB, Inciardi JA, et al. HIV seropositivity of needles from shooting galleries in South Florida. Am J Public Health 1990;80:150-2.
45. Shah SM, Shapshak P, Rivers JE, et al. Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:301-6.
46. Shapshak P, Fujimura RK, Page JB, et al. HIV-1 RNA load in needles/syringes from shooting galleries in Miami: a preliminary laboratory report. Drug Alcohol Depend 2000;58:153-7.
47. Latkin CA, Mandell W, Vlahov D, et al. Personal network characteristics as antecedents to patterns of needle sharing and shooting gallery attendance. Social Networks 1995;17:219-28.